Back to Directory
Last Updated: 09/06/2026

Carcinotech

Edinburgh
Founded 2018
3D-bioprinted patient-derived tumour models for oncology drug screening

Carcinotech is a contract research and tumour model manufacturing company that produces 3D-bioprinted micro-tumours for preclinical oncology drug screening and personalised medicine testing.

Using patient-derived biopsies, primary cells, immune cells, and cancer stem cells, its platform generates assay-ready living tumour models via robotic automated manufacturing.

The models are supplied to pharmaceutical companies, biotechs, and clinicians as alternatives to animal models for cancer drug discovery, treatment efficacy testing, and cancer biology research.